Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AltruBio
Biotech
AltruBio raises $225M for midphase ulcerative colitis program
AltruBio has roared back after another pivot in its twisty history, securing $225 million to test an immune checkpoint enhancer in ulcerative colitis.
Nick Paul Taylor
May 21, 2024 8:00am
AltruBio snags new CMO with pivot to immunology—Chutes & Ladders
Sep 17, 2021 9:30am
AltruBio snags a CMO after immunology pivot
Sep 13, 2021 10:52am
All-new AltruBio relaunches with $63M Series A
Apr 15, 2021 8:00am
